Mortality and Adverse Events After Protamine Administration in Patients Undergoing Cardiopulmonary Bypass
- 1 June 2002
- journal article
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 94 (6), 1402-1408
- https://doi.org/10.1213/00000539-200206000-00005
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Estimating Causal Effects from Large Data Sets Using Propensity ScoresAnnals of Internal Medicine, 1997
- Identification of preoperative variables needed for risk adjustment of short-term mortality after coronary artery bypass graft surgeryJournal of the American College of Cardiology, 1996
- Factors predictive of operative mortality among coronary artery bypass subsetsThe Annals of Thoracic Surgery, 1993
- A model to predict survival at time of postcardiotomy intraaortic balloon pump insertionThe Annals of Thoracic Surgery, 1993
- Multivariate prediction of in-hospital mortality associated with coronary artery bypass graft surgery. Northern New England Cardiovascular Disease Study Group.Circulation, 1992
- Prophylactic administration of histamine1 and histamine2 receptor blockers in the prevention of protamine-related haemodynamic effectsCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 1990
- A prospective study of the risk of an immediate adverse reaction to protamine sulfate during cardiopulmonary bypass surgeryJournal of Allergy and Clinical Immunology, 1990
- Association of Protamine IgE and IgG Antibodies with Life-Threatening Reactions to Intravenous ProtamineNew England Journal of Medicine, 1989
- Anaphylactoid reactions to protamine: An often lethal complication in insulin-dependent diabetic patients undergoing vascular surgeryJournal of Vascular Surgery, 1989
- ProtamineAnesthesia & Analgesia, 1985